Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Rossari Biotech has informed that it enclosed the disclosure of Related Party Transactions on a consolidated basis, in the prescribed format, for the half year ended September 30, 2022.
The above information is a part of company’s filings submitted to BSE.